Showing 81-90 of 1407 results for "".
Movement Disorders Focus: Thinking Outside the Brain
https://practicalneurology.com/diseases-diagnoses/movement-disorders/movement-disorders-focusthinking-outside-the-brain/30681/Alpha-synuclein pathology linked to Parkinson's is being detected outside the brain, in places like the salivary glands, retina and colon.Generalized Myasthenia Gravis: Inside the MINT Trial and CD19 B-Cell Therapy Advances
https://practicalneurology.com/diseases-diagnoses/neuromuscular/generalized-myasthenia-gravis-inside-the-mint-trial-and-cd19-b-cell-therapy-advances/57164/Richard J. Nowak, MD, MS, Associate Professor of Neurology, Yale School of Medicine, Yale University, New Haven, CT and global principal investigator of the Myasthenia Gravis Inebilizumab Trial (MINT), discusses the phase 3 results, highlighting the safety and efficacy of CD19-targeted B-cell therapFocused Ultrasound for Parkinson's Tremor: An Update
https://practicalneurology.com/diseases-diagnoses/movement-disorders/focused-ultrasound-for-parkinsons-tremor-an-update/30693/Data to date suggest that focused ultrasound may provide a non-invasive, non-pharmacologic option to treat the tremor of PD.Innovations in Parkinson's Disease: Deep Brain Stimulation and Magnetic Resonance-guided Focused Ultrasound
https://practicalneurology.com/diseases-diagnoses/movement-disorders/innovations-in-parkinsons-disease-deep-brain-stimulation-and-magnetic-resonance-guided-focused-ultrasound/30500/Rapid progress in deep brain stimulation and focused ultrasound offer a glimpse of the future of treatment for Parkinson's disease.- Therapeutics Q&Ahttps://practicalneurology.com/columns/practice-management/therapeutics-qa/31129/Pharmacological Management of Myasthenia Gravis in Young Adults Versus Older PatientsManaging myasthenia gravis (MG) requires tailored pharmacological strategies, especially when comparing young adults to older individuals with similar disease severity. Experts Dr. Henry J. Kaminski and Dr. Zohar Ar
Convention Question: What Will Drive the Next Great Advance in Stroke Treatment?
https://practicalneurology.com/diseases-diagnoses/stroke/convention-question-what-will-drive-the-next-great-advance-in-stroke-treatment/30121/Answers from attendees of the International Stroke Conference in Honolulu, HI, Feb 6th-8th, 2019.- Expert Opinionhttps://practicalneurology.com/columns/practice-management/expert-opinion/31314/Persistent Cognitive Deficits Post-Motor Vehicle Accident: A Case Study and Insights on Malingering in Neurological PracticeA 35-year-old male, Mr. M., presented five months after sustaining a whiplash injury from a motor vehicle accident. Initially treated by his chiropractor, Dr. J., Mr. M. contin
Building Confidence in Alzheimer Disease Care: Real-World Communication Strategies
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/building-confidence-in-alzheimer-disease-care-real-world-communication-strategies/67052/This overview provides communication tips and tactics for clinicians caring for people with Alzheimer disease in clinical practice.Tysabri and MS: Putting the Odds in the Patient's Favor
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/tysabri-and-ms-putting-the-odds-in-the-patients-favor/30762/A recent analysis has created a better profile of who can receive Tysabri and when.Parkinson's Study Looks for Prodromal and Disease Progression Biomarkers
https://practicalneurology.com/diseases-diagnoses/movement-disorders/parkinsons-study-looks-for-prodromal-and-disease-progression-biomarkers/30692/A Summary by the Parkinson's Progression Marker's Initiative (PPMI)